Unique Assay For DRG:HYBRID-XL®: Hepcidin 25 (Bioactive)

Jul 28, 2016Products

DRG is proud to announce that Hepcidin 25 (bioactive) is now available for DRG:HYBRiD-XL.

The new assay include 40 tests and has an incubation time of 120 min in total. Serum or plasma samples can be run with this test.

You may order with the following catalog number: Hepcidin 25 (bioactive) HYE-5769.

hepcidin-25-blog

[starbox]

News and Updates

BioCheck Inc Acquires DRG International Inc

by Oleg Vishnevski | Aug 18, 2021 | News | 0 Comments

Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA and Chemiluminescent immunoassay platforms.

Parasites & Helicobacter Pylori in Egyptian Children | Calprotectin- DRG:HYBRiD-XL

by Oleg Vishnevski | Apr 8, 2021 | News, Products | 0 Comments

Parasites & Helicobacter Pylori in Egyptian Children with or without Diabetes with Gastrointestinal Manifestations & High Calprotectin Level

Cortisol & Adrenal Androgens as Independent Predictors

by Oleg Vishnevski | Jan 28, 2021 | Products | 0 Comments

Cortisol and adrenal androgens as independent predictors of mortality in septic patients. Abstract Background and Objective To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-sulfate (DHEAS), together with their...

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.